Doctor Tomas Stojanov

About: With more than 26 years of experience in the health, biotechnology and agriculture sectors in a range of capacities, Tomas has conducted scientific research and has worked in operational management and commercialisation roles. Immediately prior to his appointment as CEO of Genea, Tomas was Director of Research and General Manager of Stem Cells and Research.

Genea Group successfully transformed from a premium IVF provider with an undeniable track record and a 30 year world leading research and development program into an international fertility company with integrated clinical, medical device and research arms, and with true global reach. The Genea virtuous circle of innovation – identified through clinical needs, R&D and commercial processes now sit at the core of Genea activities.